{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T04:18:23Z","timestamp":1790050703398,"version":"4.0.1"},"reference-count":39,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2017.01869","type":"journal-article","created":{"date-parts":[[2017,12,22]],"date-time":"2017-12-22T04:22:12Z","timestamp":1513916532000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":25,"title":["GATA2 Deficiency and Epstein\u2013Barr Virus Disease"],"prefix":"10.3389","volume":"8","author":[{"given":"Jeffrey I.","family":"Cohen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,12,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40164-015-0024-z","article-title":"GATA family transcriptional factors: emerging suspects in hematologic disorders","volume":"4","author":"Gao","year":"2015","journal-title":"Exp Hematol Oncol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1182\/blood-2016-09-687889","article-title":"GATA factor mutations in hematologic disease","volume":"129","author":"Crispino","year":"2017","journal-title":"Blood"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.critrevonc.2011.04.007","article-title":"The role of the GATA2 transcription factor in normal and malignant hematopoiesis","volume":"82","author":"Vicente","year":"2012","journal-title":"Crit Rev Oncol Hematol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/371221a0","article-title":"An early haematopoietic defect in mice lacking the transcription factor GATA-2","volume":"371","author":"Tsai","year":"1994","journal-title":"Nature"},{"key":"B5","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1182\/blood-2004-08-2989","article-title":"Haploinsufficiency of GATA-2 perturbs adult hematopoietic stem-cell homeostasis","volume":"106","author":"Rodrigues","year":"2005","journal-title":"Blood"},{"key":"B6","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1084\/jem.20031556","article-title":"GATA-2 plays two functionally distinct roles during the ontogeny of hematopoietic stem cells","volume":"200","author":"Ling","year":"2004","journal-title":"J Exp Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"4862","DOI":"10.1182\/blood-2008-01-136564","article-title":"GATA-2 regulates granulocyte-macrophage progenitor cell function","volume":"112","author":"Rodrigues","year":"2008","journal-title":"Blood"},{"key":"B8","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/bjh.13317","article-title":"Haematopoietic and immune defects associated with GATA2 mutation","volume":"169","author":"Collin","year":"2015","journal-title":"Br J Haematol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1097\/ACI.0000000000000126","article-title":"GATA2 deficiency","volume":"15","author":"Hsu","year":"2015","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1002\/cam4.384","article-title":"Spectrum of myeloid neoplasms and immune deficiency associated with germline GATA2 mutations","volume":"4","author":"Mir","year":"2015","journal-title":"Cancer Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1182\/blood-2013-07-515528","article-title":"GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity","volume":"123","author":"Spinner","year":"2014","journal-title":"Blood"},{"key":"B12","doi-asserted-by":"publisher","first-page":"3830","DOI":"10.1182\/blood-2012-08-452763","article-title":"GATA2 haploinsufficiency caused by mutations in a conserved intronic element leads to MonoMAC syndrome","volume":"121","author":"Hsu","year":"2013","journal-title":"Blood"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1182\/blood-2011-06-360313","article-title":"Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency","volume":"118","author":"Dickinson","year":"2011","journal-title":"Blood"},{"key":"B14","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1146\/annurev-immunol-032414-112326","article-title":"The immunology of Epstein-Barr virus-induced disease","volume":"33","author":"Taylor","year":"2015","journal-title":"Annu Rev Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"3725","DOI":"10.1182\/blood.V99.10.3725","article-title":"Epstein-Barr virus inhibits the development of dendritic cells by promoting apoptosis of their monocyte precursors in the presence of granulocyte macrophage-colony-stimulating factor and interleukin-4","volume":"99","author":"Li","year":"2002","journal-title":"Blood"},{"key":"B16","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1182\/blood-2013-07-517151","article-title":"The evolution of cellular deficiency in GATA2 mutation","volume":"123","author":"Dickinson","year":"2014","journal-title":"Blood"},{"key":"B17","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1084\/jem.174.4.915","article-title":"Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression","volume":"174","author":"de Waal Malefyt","year":"1991","journal-title":"J Exp Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1006\/viro.2002.1716","article-title":"Epstein-Barr virus encoded interleukin-10 inhibits HLA-class I, ICAM-1, and B7 expression on human monocytes: implications for immune evasion by EBV","volume":"304","author":"Salek-Ardakani","year":"2002","journal-title":"Virology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jaci.2014.01.041","article-title":"Presence of hypogammaglobulinemia and abnormal antibody responses in GATA2 deficiency","volume":"134","author":"Chou","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1182\/blood-2014-06-580340","article-title":"GATA2 deficiency-associated bone marrow disorder differs from idiopathic aplastic anemia","volume":"125","author":"Ganapathi","year":"2015","journal-title":"Blood"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1182\/blood-2012-09-453969","article-title":"Mutations in GATA2 cause human NK cell deficiency with specific loss of the CD56(bright) subset","volume":"121","author":"Mace","year":"2013","journal-title":"Blood"},{"key":"B22","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3389\/fimmu.2016.00323","article-title":"NK cell influence on the outcome of primary Epstein-Barr virus infection","volume":"7","author":"Chijioke","year":"2016","journal-title":"Front Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e27","DOI":"10.1371\/journal.ppat.0040027","article-title":"Tonsilar NK cells restrict B cell transformation by the Epstein-Barr virus via IFN-gamma","volume":"4","author":"Strowig","year":"2008","journal-title":"PLoS Pathog"},{"key":"B24","doi-asserted-by":"publisher","first-page":"4261","DOI":"10.1128\/JVI.03497-12","article-title":"The myeloid transcription factor GATA-2 regulates the viral UL144 gene during human cytomegalovirus latency in an isolate-specific manner","volume":"87","author":"Poole","year":"2013","journal-title":"J Virol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1099\/vir.0.031377-0","article-title":"Virally induced changes in cellular microRNAs maintain latency of human cytomegalovirus in CD34+ progenitors","volume":"92","author":"Poole","year":"2011","journal-title":"J Gen Virol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s00430-015-0401-6","article-title":"Sleepless latency of human cytomegalovirus","volume":"204","author":"Poole","year":"2015","journal-title":"Med Microbiol Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1128\/JVI.76.3.1285-1292.2002","article-title":"Potent immunosuppressive activities of cytomegalovirus-encoded interleukin-10","volume":"76","author":"Spencer","year":"2002","journal-title":"J Virol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e1002704","DOI":"10.1371\/journal.ppat.1002704","article-title":"The EBV immunoevasins vIL-10 and BNLF2a protect newly infected B cells from immune recognition and elimination","volume":"8","author":"Jochum","year":"2012","journal-title":"PLoS Pathog"},{"key":"B29","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/cid\/ciw160","article-title":"Association of GATA2 deficiency with severe primary Epstein-Barr virus (EBV) infection and EBV-associated cancers","volume":"63","author":"Cohen","year":"2016","journal-title":"Clin Infect Dis"},{"key":"B30","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/mus.25581","article-title":"Subacute demyelinating polyradiculoneuropathy complicating Epstein-Barr virus infection in GATA2 haploinsufficiency","volume":"57","author":"Kazamel","year":"2017","journal-title":"Muscle Nerve"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1016\/j.bbmt.2014.08.004","article-title":"Nonmyeloablative allogeneic hematopoietic stem cell transplantation for GATA2 deficiency","volume":"20","author":"Grossman","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"B32","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1093\/cid\/cit368","article-title":"MonoMAC syndrome in a patient with a GATA2 mutation: case report and review of the literature","volume":"57","author":"Camargo","year":"2013","journal-title":"Clin Infect Dis"},{"key":"B33","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s10875-016-0360-8","article-title":"Resolution of multifocal Epstein-Barr virus-related smooth muscle tumor in a patient with GATA2 deficiency following hematopoietic stem cell transplantation","volume":"37","author":"Parta","year":"2017","journal-title":"J Clin Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1038\/leu.2013.105","article-title":"Highly variable clinical manifestations in a large family with a novel GATA2 mutation","volume":"27","author":"Mutsaers","year":"2013","journal-title":"Leukemia"},{"key":"B35","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12890-015-0006-2","article-title":"Diffuse parenchymal lung disease as first clinical manifestation of GATA-2 deficiency in childhood","volume":"15","author":"Svobodova","year":"2015","journal-title":"BMC Pulm Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"3715","DOI":"10.1182\/blood-2011-06-365049","article-title":"Successful allogeneic hematopoietic stem cell transplantation for GATA2 deficiency","volume":"118","author":"Cuellar-Rodriguez","year":"2011","journal-title":"Blood"},{"key":"B37","doi-asserted-by":"publisher","first-page":"5835","DOI":"10.1182\/blood-2010-11-316745","article-title":"Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States","volume":"117","author":"Cohen","year":"2011","journal-title":"Blood"},{"key":"B38","doi-asserted-by":"publisher","first-page":"5113","DOI":"10.1182\/blood-2013-02-486324","article-title":"Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation","volume":"121","author":"Leen","year":"2013","journal-title":"Blood"},{"key":"B39","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ajhg.2017.06.004","article-title":"From peas to disease: modifier genes, network resilience, and the genetics of health","volume":"101","author":"Riordan","year":"2017","journal-title":"Am J Hum Genet"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.01869\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,12,22]],"date-time":"2017-12-22T04:22:16Z","timestamp":1513916536000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.01869\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,22]]},"references-count":39,"alternative-id":["10.3389\/fimmu.2017.01869"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2017.01869","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,22]]},"article-number":"1869"}}